The prodisc C Vivo and prodisc C Nova systems have been in clinical use globally since 2009. Credit: Centinel Spine. · Medical Device Network · Centinel Spine. Centinel Spine has received ...

NEW YORK, Dec. 22, 2017 /PRNewswire/ -- Centinel Spine, LLC (CS) is pleased to announce the acquisition of the worldwide assets of the prodisc® Total Disc Replacement portfolio from DePuy Synthes ...

(HealthDay News) – Local facet joint contact pressures are not significantly altered during sagittal bending after the implantation of a ProDisc-C device at the C5–C6 level in cadaveric human cervical ...

Record full-year 2024 prodisc® Total Disc Replacement (TDR) revenue of over $95 million in sales, up 38% over prior year. Full-year 2024 prodisc TDR sales broke records in both U.S. and International ...

Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Two-year results of an investigational device exemption study on total disc replacement using ...

WEST CHESTER, PA, January 6, 2026 (EZ Newswire) -- Centinel Spine®, the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete ...

The motion-sparing advantages offered by a semiconstrained total disc prosthesis make it a promising alternative to discectomy and fusion for treating cervical spondylosis and degenerative disc ...

ZURICH, April 15 (Reuters) - Swiss medical device maker Synthes said the reimbursement of its artificial spine disc ProDisc-C in the United States has disappointed so far. "Only one private insurer ...

WEST CHESTER, Pa., Oct. 26, 2023 /PRNewswire/ -- Centinel Spine ®, LLC, ("the Company") the leading global medical device company addressing cervical and lumbar spinal disease with the most clinically ...

Centinel Spine has received certification under the European Union (EU) Medical Device Regulation (MDR) for its prodisc C Vivo and prodisc C Nova cervical total disc replacement (TDR) systems. The ...